已发表的部分文献: 标题:All-trans retinoic acid and sodium butyrate enhance natriuretic peptide receptor a gene transcription: role of histone modification.作者:Kumar P, Periyasamy R, Das S, Neerukonda S, Mani I, Pandey KN;杂志名称:Mol Pharmacol 标题:Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1.作者:Kumar P, Tripathi S, Pandey KN;杂志名称:J Biol Chem 标题:Novel detection of post-translational modifications in human monocyte-derived dendritic cells after chronic alcohol exposure: Role of inflammation regulator H4K12ac.作者:Parira T, Figueroa G, Laverde A, Casteleiro G, Gomez Hernandez ME, Fernandez-Lima F, Agudelo M;杂志名称:Sci Rep 标题:Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer.作者:Liu W, Cui Y, Ren W, Irudayaraj J;杂志名称:Clin Epigenetics 标题:Reprograming of epigenetic mechanisms controlling host insect immunity and development in response to egg-laying by a parasitoid wasp.作者:Özbek R, Mukherjee K, Uçkan F, Vilcinskas A;杂志名称:Proc Biol Sci Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。